IR@PKUHSC  > 北京大学第二临床医学院  > 骨肿瘤科
学科主题临床医学
Arsenic trioxide inhibits Ewing′s sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase
Zhang, Shuai; Guo, Wei; Ren, Ting-Ting; Lu, Xin-Chang; Tang, Guo-Qing; Zhao, Fu-Long
关键词Arsenic Trioxide Ewing&Prime s Sarcoma Invasion Migration Mitogenactivated Protein Kinase
刊名ANTI-CANCER DRUGS
2012
DOI10.1097/CAD.0b013e32834bfd68
23期:1页:108-118
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Pharmacology & Pharmacy
资助者National Natural Science Foundation of China ; National Natural Science Foundation of China
研究领域[WOS]Oncology ; Pharmacology & Pharmacy
关键词[WOS]ACUTE PROMYELOCYTIC LEUKEMIA ; PRIMITIVE NEUROECTODERMAL TUMOR ; FACTOR-KAPPA-B ; MATRIX METALLOPROTEINASES ; INDUCED APOPTOSIS ; INVASION ; JNK ; ACTIVATION ; MIGRATION ; SURVIVAL
英文摘要

Ewing′s sarcoma is the second most frequent primary malignant bone tumor, mainly affecting children and young adults. The notorious metastatic capability of this tumor aggravates patient mortality and remains a problem to be overcome. We investigated the effect of arsenic trioxide (As2O3) on the metastasis capability of Ewing′s sarcoma cells. We performed 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide assays to choose appropriate concentrations of As2O3 for the experiments. Migration, invasion, and adhesion assays were performed to assess the effect of As2O3 on the metastasis of Ewing′s sarcoma. Immunofluorescent staining was used to observe cytoskeleton reorganization in Ewing′s sarcoma cells treated with As2O3. Changes in matrix metalloproteinase-9 expression and the mitogen-activated protein kinase (MAPK) pathway were investigated using western blot. Inhibitors of p38(MAPK) (sb202190) and c-Jun NH2-terminal kinase (JNK, sp600125) were used in invasion assays to determine the effect of p38(MAPK) and JNK. We found that As2O3 may markedly inhibit the migration and invasion capacity of Ewing′s sarcoma cells with structural rearrangements of the actin cytoskeleton. The expressions of matrix metalloproteinase-9, phosphor-p38(MAPK), and phosphor-JNK were suppressed by As2O3 treatment in a dose-dependent manner. The inhibitors of p38(MAPK) (sb202190) and JNK (sp600125) enhanced the inhibition induced by As2O3, which was counteracted by anisomycin, an activating agent of p38(MAPK) and JNK. Taken together, our results demonstrate that As2O3 can inhibit the metastasis capability of RD-ES and A-673 cells and may have new therapeutic value for Ewing′s sarcoma. Anti-Cancer Drugs 23:108-118 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.

语种英语
所属项目编号30973020
资助者National Natural Science Foundation of China ; National Natural Science Foundation of China
WOS记录号WOS:000298135900012
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54073
专题北京大学第二临床医学院_骨肿瘤科
作者单位Peking Univ, Peoples Hosp, Musculoskeletal Tumor Ctr, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Shuai,Guo, Wei,Ren, Ting-Ting,et al. Arsenic trioxide inhibits Ewing′s sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase[J]. ANTI-CANCER DRUGS,2012,23(1):108-118.
APA Zhang, Shuai,Guo, Wei,Ren, Ting-Ting,Lu, Xin-Chang,Tang, Guo-Qing,&Zhao, Fu-Long.(2012).Arsenic trioxide inhibits Ewing′s sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.ANTI-CANCER DRUGS,23(1),108-118.
MLA Zhang, Shuai,et al."Arsenic trioxide inhibits Ewing′s sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase".ANTI-CANCER DRUGS 23.1(2012):108-118.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Shuai]的文章
[Guo, Wei]的文章
[Ren, Ting-Ting]的文章
百度学术
百度学术中相似的文章
[Zhang, Shuai]的文章
[Guo, Wei]的文章
[Ren, Ting-Ting]的文章
必应学术
必应学术中相似的文章
[Zhang, Shuai]的文章
[Guo, Wei]的文章
[Ren, Ting-Ting]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。